Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.
Cancer Chemother Pharmacol
; 83(6): 1105-1112, 2019 06.
Article
in En
| MEDLINE
| ID: mdl-30968179
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Antineoplastic Combined Chemotherapy Protocols
Type of study:
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: